Autolus Therapeutics
AUTL
50 hedge funds and large institutions have $230M invested in Autolus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 8 closing their positions.
134% more capital invested
Capital invested by funds: $98.4M → $230M (+$131M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 51 → 50 (-1)
3.8% less ownership
Funds ownership: 31.23% → 27.43% (-3.8%)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$3.65M |
| 2 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$1.86M |
| 3 |
BlackRock
New York
|
+$1.37M |
| 4 |
Morgan Stanley
New York
|
+$1M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$665K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$6.39M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$5.23M |
| 3 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$4.13M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.43M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.73M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JAM
51
Jupiter Asset Management
London,
United Kingdom
| – | -$4.13M | -705,356 | Closed |
|
52
Point72 Asset Management
Stamford,
Connecticut
| – | -$746K | -124,463 | Closed |
|
|
VIA
53
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$670K | -111,832 | Closed |
|
|
VEA
54
Virtus ETF Advisers
New York
| – | -$170K | -28,428 | Closed |
|
|
AG
55
Aperio Group
Sausalito,
California
| – | -$110K | -18,317 | Closed |
|
|
S
56
SignatureFD
Atlanta,
Georgia
| – | -$3K | -516 | Closed |
|
|
PA
57
Parallel Advisors
San Francisco,
California
| – | -$1K | -323 | Closed |
|
|
CSS
58
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$1K | -245 | Closed |
|
AUTL Hedge Fund Activity: Q2 2020 in Review
50 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q2 2020, worth a combined $230M — up 134% from $98.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AUTL and 7 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 13 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $3.65M. The largest seller was Victory Capital Management, cutting an estimated $6.39M.
- 50 institutional investors held Autolus Therapeutics (AUTL) as of Q2 2020, down from 51 in Q1 2020.
- Funds reported $230M of Autolus Therapeutics stock for Q2 2020, up 134% quarter-over-quarter.
- 7 funds opened new Autolus Therapeutics positions in Q2 2020 and 8 closed out, a net change of -1 holder.
- The largest Autolus Therapeutics buyer in Q2 2020 was Baker Bros. Advisors, an estimated $3.65M added.
- The largest Autolus Therapeutics seller in Q2 2020 was Victory Capital Management, an estimated $6.39M sold.
Based on aggregated 13F filings for Q2 2020.